Platelets: A critical link between inflammation and microvascular dysfunction

Journal of Physiology

Volumn 590, Issue 5, 2012, Pages 1023-1034

  Stokes, Karen Y ^a   Granger, D Neil ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; RANTES;

CARDIOVASCULAR DISEASE; CELL FUNCTION; CELL INTERACTION; ENTERITIS; EXPERIMENTAL MODEL; HUMAN; INFLAMMATION; LEUKOCYTE; MALIGNANT NEOPLASTIC DISEASE; MICROANGIOPATHY; MICROVASCULAR ENDOTHELIAL CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEPSIS; SICKLE CELL ANEMIA; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION;

ANIMALS; BLOOD PLATELETS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; LEUKOCYTES; MICROVESSELS;

EID: 84857677456     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.225417     Document Type: Review

References (97)

1. Albrecht EA, Chinnaiyan AM, Varambally S, Kumar-Sinha C, Barrette TR, Sarma JV & Ward PA (2004). C5a-induced gene expression in human umbilical vein endothelial cells. Am J Pathol 164, 849-859.
2. Andoh A, Yoshida T, Yagi Y, Bamba S, Hata K, Tsujikawa T, Kitoh K, Sasaki M & Fujiyama Y (2006). Increased aggregation response of platelets in patients with inflammatory bowel disease. J Gastroenterol 41, 47-54.
3. Appay V & Rowland-Jones SL (2001). RANTES: a versatile and controversial chemokine. Trends Immunol 22, 83-87.
4. Aukrust P, Ueland T, Muller F, Andreassen AK, Nordoy I, Aas H, Kjekshus J, Simonsen S, Froland SS & Gullestad L (1998). Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation 97, 1136-1143.
5. Baltus T, Weber KS, Johnson Z, Proudfoot AE & Weber C (2003). Oligomerization of RANTES is required for CCR1-mediated arrest but not CCR5-mediated transmigration of leukocytes on inflamed endothelium. Blood 102, 1985-1988.
6. Bambace NM & Holmes CE (2011). The platelet contribution to cancer progression. J Thromb Haemost 9, 237-249.
7. Bavendiek U, Libby P, Kilbride M, Reynolds R, Mackman N & Schonbeck U (2002). Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor κB, and Egr-1. J Biol Chem 277, 25032-25039.
8. 3 integrin, and GPIbα. J Exp Med 187, 329-339.
9. Brockmann MA, Bender B, Plaxina E, Nolte I, Erber R, Lamszus K, Groden C & Schilling L (2011). Differential effects of tumor-platelet interaction in vitro and in vivo in glioblastoma. J Neurooncol 105, 45-56.
10. Broeders MA, Tangelder GJ, Slaaf DW, Reneman RS & Egbrink MG (2002). Hypercholesterolemia enhances thromboembolism in arterioles but not venules: complete reversal by L-arginine. Arterioscler Thromb Vasc Biol 22, 680-685.
11. Cerwinka WH, Cooper D, Krieglstein CF, Ross CR, McCord JM & Granger DN (2003). Superoxide mediates endotoxin-induced platelet-endothelial cell adhesion in intestinal venules. Am J Physiol Heart Circ Physiol 284, H535-541.
12. Clark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, Kelly MM, Patel KD, Chakrabarti S, McAvoy E, Sinclair GD, Keys EM, Allen-Vercoe E, Devinney R, Doig CJ, Green FH & Kubes P (2007). Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 13, 463-469.
13. Coeffier E, Delautier D, Couedic Le JP, Chignard M, Denizot Y & Benveniste J (1990). Cooperation between platelets and neutrophils for paf-acether (platelet-activating factor) formation. J Leukoc Biol 47, 234-243.
14. Coppinger JA, Cagney G, Toomey S, Kislinger T, Belton O, McRedmond JP, Cahill DJ, Emili A, Fitzgerald DJ & Maguire PB (2004). Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 103, 2096-2104.
15. Coussens LM & Werb Z (2002). Inflammation and cancer. Nature 420, 860-867.
16. Cox D, Kerrigan SW & Watson SP (2011). Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation. J Thromb Haemost 9, 1097-1107.
17. Danese S, Motte de la C, Sturm A, Vogel JD, West GA, Strong SA, Katz JA & Fiocchi C (2003a). Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology 124, 1249-1264.
18. Danese S, Katz JA, Saibeni S, Papa A, Gasbarrini A, Vecchi M & Fiocchi C (2003b). Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut 52, 1435-1441.
19. Conde I Del, Cruz MA, Zhang H, Lopez JA & Afshar-Kharghan V (2005). Platelet activation leads to activation and propagation of the complement system. J Exp Med 201, 871-879.
20. Demers M, Ho-Tin-Noe B, Schatzberg D, Yang JJ & Wagner DD (2011). Increased efficacy of breast cancer chemotherapy in thrombocytopenic mice. Cancer Res 71, 1540-1549.
21. Dignat-George F & Boulanger CM (2011). The many faces of endothelial microparticles. Arterioscler Thromb Vasc Biol 31, 27-33.
22. Santos dos AC, Barsante MM, Arantes RM, Bernard CC, Teixeira MM & Carvalho-Tavares J (2005). CCL2 and CCL5 mediate leukocyte adhesion in experimental autoimmune encephalomyelitis - an intravital microscopy study. J Neuroimmunol 162, 122-129.
23. Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD Jr, Wrobleski SK, Wakefield TW, Hartwig JH & Wagner DD (2010). Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A 107, 15880-15885.
24. Gavins F, Yilmaz G & Granger DN (2007). The evolving paradigm for blood cell-endothelial cell interactions in the cerebral microcirculation. Microcirculation 14, 667-681.
25. Gavins FN, Li G, Russell J, Perretti M & Granger DN (2011). Microvascular thrombosis and CD40/CD40L signaling. J Thromb Haemost 9, 574-581.
26. Gleissner CA, Hundelshausen von P & Ley K (2008). Platelet chemokines in vascular disease. Arterioscler Thromb Vasc Biol 28, 1920-1927.
27. Hamad OA, Ekdahl KN, Nilsson PH, Andersson J, Magotti P, Lambris JD & Nilsson B (2008). Complement activation triggered by chondroitin sulfate released by thrombin receptor-activated platelets. J Thromb Haemost 6, 1413-1421.
28. Hammer DA & Apte SM (1992). Simulation of cell rolling and adhesion on surfaces in shear flow: general results and analysis of selectin-mediated neutrophil adhesion. Biophys J 63, 35-57.
29. He P, Zhang H, Zhu L, Jiang Y & Zhou X (2006). Leukocyte-platelet aggregate adhesion and vascular permeability in intact microvessels: role of activated endothelial cells. Am J Physiol Heart Circ Physiol 291, H591-599.
30. Hidalgo A, Chang J, Jang JE, Peired AJ, Chiang EY & Frenette PS (2009). Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury. Nat Med 15, 384-391.
31. Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, Littman DR, Weber C & Ley K (2003). Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 9, 61-67.
32. Ishikawa M, Cooper D, Arumugam TV, Zhang JH, Nanda A & Granger DN (2004). Platelet-leukocyte-endothelial cell interactions after middle cerebral artery occlusion and reperfusion. J Cereb Blood Flow Metab 24, 907-915.
33. Kato S, Amano H, Ito Y, Eshima K, Aoyama N, Tamaki H, Sakagami H, Satoh Y, Izumi T & Majima M (2010). Effect of erythropoietin on angiogenesis with the increased adhesion of platelets to the microvessels in the hind-limb ischemia model in mice. J Pharmacol Sci 112, 167-175.
34. Kim MH, Carter PR & Harris NR (2007). P-selectin-mediated adhesion impairs endothelium-dependent arteriolar dilation in hypercholesterolemic mice. Am J Physiol Heart Circ Physiol 292, H632-638.
35. Kim MH, Curry FR & Simon SI (2009). Dynamics of neutrophil extravasation and vascular permeability are uncoupled during aseptic cutaneous wounding. Am J Physiol Cell Physiol 296, C848-856.
36. Kim YJ, Borsig L, Varki NM & Varki A (1998). P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci U S A 95, 9325-9330.
37. Kisucka J, Butterfield CE, Duda DG, Eichenberger SC, Saffaripour S, Ware J, Ruggeri ZM, Jain RK, Folkman J & Wagner DD (2006). Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. Proc Natl Acad Sci U S A 103, 855-860.
38. Kupatt C, Wichels R, Horstkotte J, Krombach F, Habazettl H & Boekstegers P (2002). Molecular mechanisms of platelet-mediated leukocyte recruitment during myocardial reperfusion. J Leukoc Biol 72, 455-461.
39. Langer HF & Gawaz M (2008). Platelet-vessel wall interactions in atherosclerotic disease. Thromb Haemost 99, 480-486.
40. Lee SP, Ataga KI, Zayed M, Manganello JM, Orringer EP, Phillips DR & Parise LV (2007). Phase I study of eptifibatide in patients with sickle cell anaemia. Br J Haematol 139, 612-620.
41. Leslie M (2010). Cell biology. Beyond clotting: the powers of platelets. Science 328, 562-564.
42. Li JM, Podolsky RS, Rohrer MJ, Cutler BS, Massie MT, Barnard MR & Michelson AD (1996). Adhesion of activated platelets to venous endothelial cells is mediated via GPIIb/IIIa. J Surg Res 61, 543-548.
43. Li N (2008). Platelet-lymphocyte cross-talk. J Leukoc Biol 83, 1069-1078.
44. Lievens D, Zernecke A, Seijkens T, Soehnlein O, Beckers L, Munnix IC, Wijnands E, Goossens P, Kruchten van R, Thevissen L, Boon L, Flavell RA, Noelle RJ, Gerdes N, Biessen EA, Daemen MJ, Heemskerk JW, Weber C & Lutgens E (2010). Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Blood 116, 4317-4327.
45. Lo SK, Burhop KE, Kaplan JE & Malik AB (1988). Role of platelets in maintenance of pulmonary vascular permeability to protein. Am J Physiol Heart Circ Physiol 254, H763-771.
46. Manthey HD, Thomas AC, Shiels IA, Zernecke A, Woodruff TM, Rolfe B & Taylor SM (2011). Complement C5a inhibition reduces atherosclerosis in ApoE-/- mice. FASEB J 25, 2447-2455.
47. Massberg S, Brand K, Gruner S, Page S, Muller E, Muller I, Bergmeier W, Richter T, Lorenz M, Konrad I, Nieswandt B & Gawaz M (2002). A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 196, 887-896.
48. Massberg S, Enders G, Matos FC, Tomic LI, Leiderer R, Eisenmenger S, Messmer K & Krombach F (1999). Fibrinogen deposition at the postischemic vessel wall promotes platelet adhesion during ischemia-reperfusion in vivo. Blood 94, 3829-3838.
49. Maugeri N, Rovere-Querini P, Evangelista V, Covino C, Capobianco A, Bertilaccio MT, Piccoli A, Totani L, Cianflone D, Maseri A & Manfredi AA (2009). Neutrophils phagocytose activated platelets in vivo: a phosphatidylserine, P-selectin, and β2 integrin-dependent cell clearance program. Blood 113, 5254-5265.
50. Mavrommatis AC, Theodoridis T, Orfanidou A, Roussos C, Christopoulou-Kokkinou V & Zakynthinos S (2000). Coagulation system and platelets are fully activated in uncomplicated sepsis. Crit Care Med 28, 451-457.
51. May AE, Seizer P & Gawaz M (2008). Platelets: inflammatory firebugs of vascular walls. Arterioscler Thromb Vasc Biol 28, s5-10.
52. Mori M, Salter JW, Vowinkel T, Krieglstein CF, Stokes KY & Granger DN (2005). Molecular determinants of the prothrombogenic phenotype assumed by inflamed colonic venules. Am J Physiol Gastrointest Liver Physiol 288, G920-926.
53. Morrell CN, Sun H, Swaim AM & Baldwin WM 3rd (2007). Platelets an inflammatory force in transplantation. Am J Transplant 7, 2447-2454.
54. Nagata K, Tsuji T, Todoroki N, Katagiri Y, Tanoue K, Yamazaki H, Hanai N & Irimura T (1993). Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin (CD62). J Immunol 151, 3267-3273.
55. Nierodzik ML, Klepfish A & Karpatkin S (1995). Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo. Thromb Haemost 74, 282-290.
56. O'Brien JG, Battistini B, Farmer P, Johnson RJ, Zaharia F, Plante GE & Sirois P (1997). Aprotinin, an antifibrinolytic drug, attenuates bradykinin-induced permeability in conscious rats via platelets and neutrophils. Can J Physiol Pharmacol 75, 741-749.
57. Pamuk GE, Vural O, Turgut B, Demir M, Umit H & Tezel A (2006). Increased circulating platelet-neutrophil, platelet-monocyte complexes, and platelet activation in patients with ulcerative colitis: a comparative study. Am J Hematol 81, 753-759.
58. Patel KN, Soubra SH, Lam FW, Rodriguez MA & Rumbaut RE (2010). Polymicrobial sepsis and endotoxemia promote microvascular thrombosis via distinct mechanisms. J Thromb Haemost 8, 1403-1409.
59. Patil S, Kaplan JE & Minnear FL (1997). Protein, not adenosine or adenine nucleotides, mediates platelet decrease in endothelial permeability. Am J Physiol Heart Circ Physiol 273, H2304-2311.
60. Paty PS, Sherman PF, Shepard JM, Malik AB & Kaplan JE (1992). Role of adenosine in platelet-mediated reduction in pulmonary vascular permeability. Am J Physiol Heart Circ Physiol 262, H771-777.
61. Peerschke EI, Yin W & Ghebrehiwet B (2010). Complement activation on platelets: implications for vascular inflammation and thrombosis. Mol Immunol 47, 2170-2175.
62. Peerschke EI, Yin W, Grigg SE & Ghebrehiwet B (2006). Blood platelets activate the classical pathway of human complement. J Thromb Haemost 4, 2035-2042.
63. Peng X, Hassoun PM, Sammani S, McVerry BJ, Burne MJ, Rabb H, Pearse D, Tuder RM & Garcia JG (2004). Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am J Respir Crit Care Med 169, 1245-1251.
64. Pipili-Synetos E, Papadimitriou E & Maragoudakis ME (1998). Evidence that platelets promote tube formation by endothelial cells on matrigel. Br J Pharmacol 125, 1252-1257.
65. Prasad KS, Andre P, Yan Y & Phillips DR (2003). The platelet CD40L/GP IIb-IIIa axis in atherothrombotic disease. Curr Opin Hematol 10, 356-361.
66. Rhodin JA, Thomas TN, Clark L, Garces A & Bryant M (2003). In vivo cerebrovascular actions of amyloid beta-peptides and the protective effect of conjugated estrogens. J Alzheimers Dis 5, 275-286.
67. Robson SC, Sevigny J & Zimmermann H (2006). The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signal 2, 409-430.
68. Sabrkhany S, Griffioen AW & Egbrink MG (2010). The role of blood platelets in tumor angiogenesis. Biochim Biophys Acta 1815, 189-196.
69. Salter JW, Krieglstein CF, Issekutz AC & Granger DN (2001). Platelets modulate ischemia/reperfusion-induced leukocyte recruitment in the mesenteric circulation. Am J Physiol Gastrointest Liver Physiol 281, G1432-1439.
70. Schaphorst KL, Chiang E, Jacobs KN, Zaiman A, Natarajan V, Wigley F & Garcia JG (2003). Role of sphingosine-1 phosphate in the enhancement of endothelial barrier integrity by platelet-released products. Am J Physiol Lung Cell Mol Physiol 285, L258-267.
71. Schmid MC, Avraamides CJ, Dippold HC, Franco I, Foubert P, Ellies LG, Acevedo LM, Manglicmot JR, Song X, Wrasidlo W, Blair SL, Ginsberg MH, Cheresh DA, Hirsch E, Field SJ & Varner JA (2011). Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3Kγ, a single convergent point promoting tumor inflammation and progression. Cancer Cell 19, 715-727.
72. Senchenkova EY, Russell J, Almeida-Paula LD, Harding JW & Granger DN (2010). Angiotensin II-mediated microvascular thrombosis. Hypertension 56, 1089-1095.
73. Shepard JM, Moon DG, Sherman PF, Weston LK, Vecchio PJ Del, Minnear FL, Malik AB & Kaplan JE (1989). Platelets decrease albumin permeability of pulmonary artery endothelial cell monolayers. Microvasc Res 37, 256-266.
74. Siegel-Axel DI & Gawaz M (2007). Platelets and endothelial cells. Semin Thromb Hemost 33, 128-135.
75. Sims PJ, Faioni EM, Wiedmer T & Shattil SJ (1988). Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 263, 18205-18212.
76. Singer G, Stokes KY & Granger DN (2008). Hepatic microcirculation in murine sepsis: role of lymphocytes. Pediatr Surg Int 24, 13-20.
77. Singer G, Urakami H, Specian RD, Stokes KY & Granger DN (2006). Platelet recruitment in the murine hepatic microvasculature during experimental sepsis: role of neutrophils. Microcirculation 13, 89-97.
78. Smyth SS, McEver RP, Weyrich AS, Morrell CN, Hoffman MR, Arepally GM, French PA, Dauerman HL & Becker RC (2009). Platelet functions beyond hemostasis. J Thromb Haemost 7, 1759-1766.
79. Stafford NP, Pink AE, White AE, Glenn JR & Heptinstall S (2003). Mechanisms involved in adenosine triphosphate-induced platelet aggregation in whole blood. Arterioscler Thromb Vasc Biol 23, 1928-1933.
80. Stokes KY, Calahan L, Hamric CM, Russell JM & Granger DN (2009). CD40/CD40L contributes to hypercholesterolemia-induced microvascular inflammation. Am J Physiol Heart Circ Physiol 296, H689-697.
81. Stokes KY, Calahan L, Russell JM, Gurwara S & Granger DN (2006). Role of platelets in hypercholesterolemia-induced leukocyte recruitment and arteriolar dysfunction. Microcirculation 13, 377-388.
82. Stokes KY, Gurwara S & Granger DN (2007). T-cell derived interferon-gamma contributes to arteriolar dysfunction during acute hypercholesterolemia. Arterioscler Thromb Vasc Biol 27, 1998-2004.
83. Suzuki K, Sugimura K, Hasegawa K, Yoshida K, Suzuki A, Ishizuka K, Ohtsuka K, Honma T, Narisawa R & Asakura H (2001). Activated platelets in ulcerative colitis enhance the production of reactive oxygen species by polymorphonuclear leukocytes. Scand J Gastroenterol 36, 1301-1306.
84. Tailor A, Cooper D & Granger DN (2005). Platelet-vessel wall interactions in the microcirculation. Microcirculation 12, 275-285.
85. Terao S, Yilmaz G, Stokes KY, Russell J, Ishikawa M, Kawase T & Granger DN (2008). Blood cell-derived RANTES mediates cerebral microvascular dysfunction, inflammation, and tissue injury after focal ischemia-reperfusion. Stroke 39, 2560-2570.
86. Todoroki N, Watanabe Y, Akaike T, Katagiri Y, Tanoue K, Yamazaki H, Tsuji T, Toyoshima S & Osawa T (1991). Enhancement by IL-1β and IFN-γ of platelet activation: adhesion to leukocytes via GMP-140/PADGEM protein (CD62). Biochem Biophys Res Commun 179, 756-761.
87. Tyml K (2011). Critical role for oxidative stress, platelets, and coagulation in capillary blood flow impairment in sepsis. Microcirculation 18, 152-162.
88. Vowinkel T, Anthoni C, Wood KC, Stokes KY, Russell J, Gray L, Bharwani S, Senninger N, Alexander JS, Krieglstein CF, Grisham MB & Granger DN (2007a). CD40-CD40 ligand mediates the recruitment of leukocytes and platelets in the inflamed murine colon. Gastroenterology 132, 955-965.
89. Vowinkel T, Wood KC, Stokes KY, Russell J, Tailor A, Anthoni C, Senninger N, Krieglstein CF & Granger DN (2007b). Mechanisms of platelet and leukocyte recruitment in experimental colitis. Am J Physiol Gastrointest Liver Physiol 293, G1054-1060.
90. Weissmuller T, Campbell EL, Rosenberger P, Scully M, Beck PL, Furuta GT & Colgan SP (2008). PMNs facilitate translocation of platelets across human and mouse epithelium and together alter fluid homeostasis via epithelial cell-expressed ecto-NTPDases. J Clin Invest 118, 3682-3692.
91. Wood K, Russell J, Hebbel RP & Granger DN (2004a). Differential expression of E- and P-selectin in the microvasculature of sickle cell transgenic mice. Microcirculation 11, 377-385.
92. Wood KC, Hebbel RP & Granger DN (2004b). Endothelial cell P-selectin mediates a proinflammatory and prothrombogenic phenotype in cerebral venules of sickle cell transgenic mice. Am J Physiol Heart Circ Physiol 286, H1608-1614.
93. Yilmaz G, Arumugam TV, Stokes KY & Granger DN (2006). Role of T lymphocytes and interferon-γ in ischemic stroke. Circulation 113, 2105-2112.
94. Yoshida H, Yilmaz CE & Granger DN (2011). Role of tumor necrosis factor-α in the extraintestinal thrombosis associated with colonic inflammation. Inflamm Bowel Dis 17, 2217-2223.
95. Zhang S, Rahman M, Herwald H & Thorlacius H (2011). Streptococcal M1 protein-induced lung injury is independent of platelets in mice. Shock 35, 86-91.
96. i and microvessel permeability in the absence of adhesion: role of reactive oxygen species. Am J Physiol Heart Circ Physiol 288, H1331-1338.
97. Zhu L & He P (2006). fMLP-stimulated release of reactive oxygen species from adherent leukocytes increases microvessel permeability. Am J Physiol Heart Circ Physiol 290, H365-372.